The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice. The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.
The aim of this research is to quantify among the patients who benefited from a dosage reduction of Benzodiazepines and related drugs during a stay in the Geriatric Care and Aftercare and Rehabilitation department, the number of patients who had an increase of this treatment within 12 weeks following discharge from hospitalization.
Study Type
OBSERVATIONAL
Enrollment
150
Gériatrie - Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France
Strasbourg, France
RECRUITINGThe number of patients who had an increase in Benzodiazepines in the 12 weeks following discharge from hospitalization.
Time frame: 12 weeks following discharge from hospitalization.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.